StockData
Airsculpt Technologies, Inc. logo

Airsculpt Technologies, Inc. (AIRS) company profile

AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3084% below fair value
$0.70−0.14 (-16.37%)

Close on Nov 16, 2026Market cap $50.47MP/E –Yield –

About Airsculpt Technologies

Services-Offices & Clinics of Doctors of Medicine, SIC 8011

AirSculpt Technologies, Inc. provides proprietary body contouring and fat removal procedures. The company specializes in minimally invasive aesthetic treatments, including fat extraction, autologous fat transfer, skin tightening, and cellulite reduction. Its proprietary offerings feature specialized fat transfer techniques to enhance areas such as the breasts, buttocks, and hips without foreign implants, alongside targeted radiofrequency and plasma skin laxity treatments. AirSculpt delivers its clinical services through affiliated professional medical associations that employ licensed cosmetic and plastic surgeons, serving individual self-pay consumer patients who seek cosmetic enhancement.

The company operates a network of 31 body contouring centers located across 20 U.S. states and Canada. Facilities are situated in affluent metropolitan and suburban commercial areas. The provided text does not state the location of the company's corporate headquarters.

Summary of the business section of Airsculpt Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
Airsculpt Technologies, Inc.
Founded
2012
Headquarters
Tampa, FL
Address
2023 West Platt Street 33605
Phone
(786) 709-9690
Employees
330, Dec 31, 2025
Industry
Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends
December 31
Auditor
GRANT THORNTON LLP, Tampa, Florida

Stock & identifiers

Ticker
AIRS
Exchange
Nasdaq
IPO date
Oct 29, 2021
Shares outstanding
72M, Aug 7, 2026
Public float
$79.80M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
1870940
CUSIP
009496100
ISIN
US0094961002
FIGI
BBG012V27C29
Share class FIGI
BBG012V27CX5
EIN
87-1471855

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yogesh JashnaniChief Executive Officer, Director726,475
Aaron RollinsExecutive Chairman, Director15,146,039
Michael J. ArthurChief Financial Officer215,086
Brent R. WadmanGENERAL COUNSEL55,272
Philip BodieChief Accounting Officer76,052
Dennis DeanChief Financial Officer660,668
Adam T. FeinsteinDirector30,324,180
Caroline ChuDirector277,066
Kenneth HigginsDirector274,066
Thomas J. AaronDirector276,866
Michael Thomas DoyleDirector375,934

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Dr. Aaron Rollins
Former Executive Chairman
$465.97K–$849.05K–$28.80K$1.34M-59%
Yogesh Jashnani
Chief Executive Officer
$660.51K$262.50K$3.92M$140.00K–$4.98M–
Dennis Dean
Former Interim Chief Executive Officer and Former Chief Financial Officer
$452.08K–$424.53K–$2.51K$879.12K-24%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Oct 29, 2021
Offer price
$11.00
Securities offered
7,000,000
Gross proceeds
$77.00M
Exchange
Nasdaq
First trading day
Oct 29, 2021
First-day close
$15.89+44.5%
Lock-up ends (est.)
Apr 27, 2022

“The initial public offering price per share of our common stock is $11.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed approximately 330 full-time employees and approximately 33 part-time employees.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?